Your browser doesn't support javascript.
loading
Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study.
Banerjee, Rupa; Chuah, Sai Wei; Hilmi, Ida Normiha; Wu, Deng-Chyang; Yang, Suk-Kyun; Demuth, Dirk; Lindner, Dirk; Adsul, Shashi.
Afiliación
  • Banerjee R; Asian Institute of Gastroenterology, Hyderabad, India.
  • Chuah SW; Singapore General Hospital, Singapore.
  • Hilmi IN; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Wu DC; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Yang SK; University of Ulsan College of Medicine, Seoul, Korea.
  • Demuth D; Takeda Pharmaceutical International AG, Singapore.
  • Lindner D; Takeda Pharmaceutical International AG, Zurich, Switzerland.
  • Adsul S; Takeda Pharmaceutical International AG, Zurich, Switzerland.
Intest Res ; 19(1): 83-94, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33378612
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Intest Res Año: 2021 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Intest Res Año: 2021 Tipo del documento: Article País de afiliación: India